MedPath

LIDOCAINE HCl

Lidocaine hydrochloride and epinephrine injection, USP(Lidocaine HCl 2% and Epinephrine 1:100,000 Injection)

Approved
Approval ID

8d3430c5-ea3a-4056-b1a1-dd651c08f93d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 15, 2012

Manufacturers
FDA

Pearson Dental

DUNS: 082874108

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine Hydrochloride and Epinephrine Bitartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43305-1030
Application NumberANDA088390
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lidocaine Hydrochloride and Epinephrine Bitartrate
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateMay 15, 2012
FDA Product Classification

INGREDIENTS (7)

Lidocaine HydrochlorideActive
Quantity: 20 mg in 1 mL
Code: V13007Z41A
Classification: ACTIB
Epinephrine BitartrateActive
Quantity: 0.01 mg in 1 mL
Code: 30Q7KI53AK
Classification: ACTIM
Potassium MetabisulfiteInactive
Quantity: 1.2 mg in 1 mL
Code: 65OE787Q7W
Classification: IACT
Sodium ChlorideInactive
Quantity: 6.5 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
Edetate DisodiumInactive
Quantity: 0.25 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LIDOCAINE HCl - FDA Drug Approval Details